Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560167 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation
A NA study, sponsored by Ancora Heart.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03560167 is a NA study that has completed, run by Ancora Heart. The registered enrollment target is 5 participants.
The verdict
NCT03560167, a NA study, has completed, sponsored by Ancora Heart.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a non-randomized, prospective, multi-center Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation.
Interventions
- DEVICE AccuCinch® Ventricular Restoration System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2024-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03560167
The ClinicalTrials.gov registry entry for NCT03560167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ancora Heart, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AccuCinch® Ventricular Restoration System is the first listed.
NCT03560167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03560167 about?
NCT03560167 is a clinical study titled "Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation". This is a non-randomized, prospective, multi-center Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation.
What is the current status of trial NCT03560167?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-09-24. Estimated completion is 2024-01-28.
What interventions are being tested in trial NCT03560167?
The interventions under investigation include: AccuCinch® Ventricular Restoration System (DEVICE).
Who is sponsoring clinical trial NCT03560167?
This trial is sponsored by Ancora Heart, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.